Orchestra BioMed Holdings (OBIO) Invested Capital (2020 - 2026)

Orchestra BioMed Holdings (OBIO) has 7 years of Invested Capital data on file, last reported at $41.2 million in Q1 2026.

• Quarterly Invested Capital rose 144.36% year-over-year to $41.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $41.2 million (up 144.36% YoY) and the FY2025 annual result came in at $53.6 million, up 62.54% from the prior year.
• Invested Capital declined to $41.2 million in Q1 2026 per OBIO's latest filing, from $53.6 million in the prior quarter.
• Across five years, Invested Capital topped out at $99.8 million in Q1 2023 and bottomed at $78000.0 in Q1 2022.
• The 5-year median for Invested Capital is $53.6 million (2025), against an average of $51.1 million.
• The widest annual swing landed in 2023, when Invested Capital jumped 127787.18%; it then slumped 99.33% in 2025.
• Tracing OBIO's Invested Capital over 5 years: stood at $54.6 million in 2022, then advanced by 24.57% to $68.0 million in 2023, then sank by 51.56% to $33.0 million in 2024, then jumped by 62.54% to $53.6 million in 2025, then fell by 23.11% to $41.2 million in 2026.
• Per Business Quant, the three latest OBIO Invested Capital figures stand at $41.2 million (Q1 2026), $53.6 million (Q4 2025), and $43.7 million (Q3 2025).

Peer Comparison